Department Of Oncology 2
51. An Anti-HIV Drug Is Highly Effective Against SARS-CoV-2 In Vitro and Has Potential Benefit for Long COVID Treatment
52. Ceratonia siliqua L. pod Effects on Viability Gene Expression of Endometrial Mesenchymal Stromal/Stem Cells Isolated from Women with Endometriosis-Associated Infertility
53. Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018
54. Mesenchymal stem cell therapy for diabetes: An umbrella review
55. The oncogenic role of human papillomavirus in breast cancer: a comprehensive systematic review and meta-analysis
56. Bibliometric analysis of tumor marker application in gastric cancer diagnosis from 2019 to 2024
57. Tandem mass spectrometry in screening for inborn errors of metabolism: comprehensive bibliometric analysis
58. Subspecialty training in Europe: A report by the European Network of Young Gynaecological Oncologists
59. A forecasting method of postoperative intestinal paralysis and its timely resolution
60. Causes of adverse outcomes in acute intestinal obstruction
61. Actual issues of secondary prevention of liver cancer in Kazakhstan
62. Prevalence of liver cancer in Kazakhstan: a systematic review
63. Trends of Colorectal Cancer Incidence in Kazakhstan
64. Incidence of and mortality due to cervical cancer in Kazakhstan
65. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
66. Potential of chimeric antigen receptor (CAR)-redirected immune cells in breast cancer therapies: Recent advances
67. Innovations in Oncology Diagnostics: Genetic Research and Liquid Biopsy as Tools of Personalised Medicine
68. Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer
69. Targeted Cancer Therapy: Leveraging Dual pH-Sensitive Polymers Nanoparticles for Doxorubicin Delivery and Tumor Suppression: A Review
70. GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
71. GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
72. Potential of E-Learning Interventions and Artificial Intelligence–Assisted Contouring Skills in Radiotherapy: The ELAISA Study
73. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019
74. The Role of Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy. Literature review
75. Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer(Pathol. Oncol. Res., (2022), 28, (1610383), 10.3389/pore.2022.1610383)
76. Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer(Pathol. Oncol. Res., (2022), 28, (1610383), 10.3389/pore.2022.1610383)
77. Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
78. Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
79. Mesenchymal stromal/stem cell-derived exosomes and genitourinary cancers: A mini review
80. Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules
81. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
82. Effects of metastatic CRC predictors on treatment outcomes
83. Immune Thrombocytopenia: Immune Dysregulation and Genetic Perturbations Deciphering the Fate of Platelets
84. The Manganese–Bone Connection: Investigating the Role of Manganese in Bone Health
85. A first approach to identifying cardiotoxic effects of breast cancer chemotherapeutic treatment in Kazakhstan
86. Role of Clinical Risk Factors and B-Type Natriuretic Peptide in Assessing the Risk of Asymptomatic Cardiotoxicity in Breast Cancer Patients in Kazakhstan †
87. Stratifying breast cancer patients by baseline risk of cardiotoxic complications linked to chemotherapy
88. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
89. A Study of the Effectiveness of Apoptosis Biomarkers in the Diagnosis of Gastric Cancer in Kazakhstan: A Review of Systematic Evidence
90. Prognostic factors of survival in patients with gastric cancer: a retrospective study in the Aktobe region for 2010-2024
91. Essential Trace Elements in Scalp Hair of Residents across the Caspian Oil and Gas Region of Kazakhstan
92. Attitude toward vaccination against COVID-19 and acceptance of the national QazVac vaccine in the Aktobe city population, West Kazakhstan: A cross-sectional survey
93. COVID-19 and Its Relationship with Social and Behavioral Factors in the Population of the Republic of Kazakhstan
94. A Clinical Nomogram to Predict Survival Outcomes in Patients with Well-Differentiated Thyroid Cancer
95. Apoptotic cell death in disease—Current understanding of the NCCD 2023
96. Apoptotic cell death in disease—Current understanding of the NCCD 2023
97. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
98. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry
99. Characteristic Mutational Damages in Gastric and Colorectal Adenocarcinomas
100. Assessing Functional Independence and Associated Factors in Older Populations of Kazakhstan: Implications for Long-Term Care
1 2 3